ASTRA NEXT HEME

Serial Number 90562697
606

Registration Progress

Application Filed
Mar 5, 2021
Under Examination
Dec 28, 2021
Approved for Publication
Nov 2, 2021
Published for Opposition
Nov 2, 2021
Registered

Trademark Image

ASTRA NEXT HEME

Basic Information

Serial Number
90562697
Filing Date
March 5, 2021
Published for Opposition
November 2, 2021
Abandonment Date
August 1, 2022
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 1, 2022
Classes
044

Rights Holder

Genosity Inc.

03
Address
Suite 110
485F Route 1 South
Iselin, NJ 08830

Ownership History

Genosity Inc.

Original Applicant
03
Iselin, NJ

Genosity Inc.

Owner at Publication
03
Iselin, NJ

Legal Representation

Attorney
Michelle L. Mehok

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Aug 1, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 1, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 1, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Feb 1, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 1, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 1, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 28, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 2, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 2, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 13, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 28, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 28, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 4, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 9, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Diagnostic testing for the detection of cancer, namely, molecular testing intended to assess the presence or absence of residual disease at various time points during an individual's hematologic cancer management

Classification

International Classes
044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"HEME"